Effectiveness of a single dose of oral misoprostol 600 μg for treatment in early pregnancy failure

References

• Aronsson A, Fiala C, Stephansson O, Granath F, Watzer B, Schweer H et al. 2007. Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol. Human Reproduction 22:1912–1918.
   PubMed Web of Science ®Google Scholar
• Bagratee JS, Khullar V, Regan L, Moodley J, Kagoro H. 2004. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Human Reproduction 19:266–271.
   PubMed Web of Science ®Google Scholar
• Child TJ, Thomas J, Rees M, MacKenzie IZ. 2001. A comparative study of surgical and medical procedures: 932 pregnancy terminations up to 63 days gestation. Human Reproduction 16:67–71.
   PubMed Web of Science ®Google Scholar
• Chung TK, Cheung LP, Sahota DS, Haines CJ, Chang AM. 1998. Evaluation of the accuracy of transvaginal sonography for the assessment of retained products of conception after spontaneous abortion. Gynecologic and Obstetric Investigation 45:190–193.
   PubMed Web of Science ®Google Scholar
• Creinin MD, Moyer R, Guido R. 1997. Misoprostol for medical evacuation of early pregnancy failure. Obstetrics and Gynecology 89:768–772.
   PubMed Web of Science ®Google Scholar
• Dao B, Blum J, Thieba B, Raghavan S, Ouedraego M, Lankoande J et al. 2007. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa. British Journal of Obstetrics and Gynaecology 114:1368–1375.
   Google Scholar
• Graziosi GC, Mol BW, Ankum WM, Bruinse HW. 2004a. Management of early pregnancy loss. International Journal of Gynaecology and Obstetrics 86:337–346.
   PubMed Web of Science ®Google Scholar
• Graziosi GC, Mol BW, Reuwer PJ, Drogtrop A, Bruinse HW. 2004b. Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Human Reproduction 19:1894–1899.
   PubMed Web of Science ®Google Scholar
• Hemminki E. 1998. Treatment of miscarriage: current practice and rationale. Obstetrics and Gynecology 91:247–253.
   PubMed Web of Science ®Google Scholar
• Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW. 1997. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstetrics and Gynecology 90:735–738.
   PubMed Web of Science ®Google Scholar
• Jurkovic D, Ross JA, Nicolaides KH. 1998. Expectant management of missed miscarriage. British Journal of Obstetrics and Gynaecology 105:670–671.
   PubMedGoogle Scholar
• Nanda K, Lopez LM, Grimes DA, Peloggia A, Nanda G. 2012. Expectant care versus surgical treatment for miscarriage. Cochrane Database of Systematic Reviews(3):CD003518.
   Google Scholar
• Ngai SW, Tang OS, Chan YM, Ho PC. 2000. Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability. Human Reproduction 15:1159–1162.
   PubMed Web of Science ®Google Scholar
• Ngoc NT, Blum J, Westheimer E, Quan TT, Winikoff B. 2004. Medical treatment of missed abortion using misoprostol. International Journal of Gynaecology and Obstetrics 87:138–142.
   PubMed Web of Science ®Google Scholar
• Paritakul P, Phupong V. 2010. Comparative study between oral and sublingual 600 μg misoprostol for the treatment of incomplete abortion. Journal of Obstetrics and Gynaecology Research 36:978–983.
   PubMed Web of Science ®Google Scholar
• Phupong V, Taneepanichskul S, Kriengsinyot R, Sriyirojana N, Blanchard K, Winikoff B. 2004. Comparative study between single dose 600 μg and repeated dose of oral misoprostol for treatment of incomplete abortion. Contraception 70:307–311.
   PubMed Web of Science ®Google Scholar
• RCR/RCOG. 1996. Working Party. Early pregnancy assessment. London: RCOG Press.
   Google Scholar
• Saichua C, Phupong V. 2009. A randomized controlled trial comparing powdery sublingual misoprostol and sublingual misoprostol tablet for management of embryonic death or anembryonic pregnancy. Archives of Gynecology and Obstetrics 280:431–435.
   PubMed Web of Science ®Google Scholar
• Tang OS, Gemzell-Danielsson K, Ho PC. 2007. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. International Journal of Gynecology and Obstetrics 99(Suppl 2):S160–S167.
   Google Scholar
• Tang OS, Lau WN, Ng EH, Lee SW, Ho PC. 2003. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages. Human Reproduction 18:176–181.
   PubMed Web of Science ®Google Scholar
• Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. 2002. Pharmacokinetics of different routes of administration of misoprostol. Human Reproduction 17:332–336.
   PubMed Web of Science ®Google Scholar
• Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. 2006. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). British Medical Journal 332:1235–1240.
   PubMed Web of Science ®Google Scholar